LLY
1,061.04
+3.27%↑
JNJ
214.42
+1.41%↑
ABBV
227.63
+1.87%↑
UNH
341.44
+0.01%↑
AZN
91.59
+2%↑
LLY
1,061.04
+3.27%↑
JNJ
214.42
+1.41%↑
ABBV
227.63
+1.87%↑
UNH
341.44
+0.01%↑
AZN
91.59
+2%↑
LLY
1,061.04
+3.27%↑
JNJ
214.42
+1.41%↑
ABBV
227.63
+1.87%↑
UNH
341.44
+0.01%↑
AZN
91.59
+2%↑
LLY
1,061.04
+3.27%↑
JNJ
214.42
+1.41%↑
ABBV
227.63
+1.87%↑
UNH
341.44
+0.01%↑
AZN
91.59
+2%↑
LLY
1,061.04
+3.27%↑
JNJ
214.42
+1.41%↑
ABBV
227.63
+1.87%↑
UNH
341.44
+0.01%↑
AZN
91.59
+2%↑
24h
Current
Min
17.43
Max
18.08
Recommendations | Buy |
|---|---|
12 Months Forecast | +93.69% upside |
Past performance is not a reliable indicator of future results.
19 Dec 2024, 00:26 UTC
Mesoblast ADRs Rise 22%, FDA Approves Ryoncil for Pediatric Patients -- Update
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 35 USD 93.69%
High 35 USD
Low 35 USD
Based on 1 Wall Street analysts offering 12 month price targets forMesoblast Ltd ADR - Dist in the last 3 months.
By TipRanks
Buy
1 ratings
1
Buy
0
Hold
0
Sell
Based on 1 analysts giving stock ratings to Mesoblast Ltd ADR - Dist in the past 3 months.
$